SCOTT HEICHMAN: Open Payments
NPI 1568974723 · WILTON MANORS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,670 in 105 payments from 15 companies in 2025. Trend: 2023 $2,402 · 2024 $3,161 · 2025 $2,670
Food & beverage: $2,670
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 50 | $1,312 |
| Gilead Sciences, Inc. | 28 | $626 |
| Braeburn Inc. | 4 | $176 |
| Theratechnologies Inc. | 5 | $172 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| EMD Serono, Inc. | 2 | $43 |
| Indivior Inc. | 1 | $38 |
| Astellas Pharma US Inc | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: DOVATO, APRETUDE, CABENUVA, BRIXADI, EGRIFTA, RUKOBIA, Yeztugo, PIFELTRO.
Industry payments across FL — which companies pay providers there.
